PET-negative gastrointestinal stromal tumors

Case Reports in Oncology

Volumn 6, Issue 3, 2013, Pages 508-513

  Williams, Anja ^a   Gutzeit, Andreas ^b   Germer, Michael ^a   Pless, Miklos ^a  

^a Kantonsspital Winterthur ^*  (Switzerland)

^b CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

Author keywords

Fluorodeoxyglucose; Gastrointestinal stromal tumors; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IMATINIB;

ABDOMINAL RADIOGRAPHY; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPY; ENDOSONOGRAPHIC BIOPSY; EPIGASTRIC PAIN; FEMALE; GASTRECTOMY; GASTROINTESTINAL STROMAL TUMOR; HEMATOMA; HISTOLOGY; HUMAN; LYMPH NODE; PALLIATIVE THERAPY; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; RECTUS ABDOMINIS MUSCLE; SOLID TUMOR; THORAX PAIN; TUMOR BIOPSY; TUMOR DIAGNOSIS; URINARY TRACT INFECTION; VERY ELDERLY; CANCER PALLIATIVE THERAPY; ENDOSCOPIC ECHOGRAPHY; GASTROINTESTINAL BIOPSY; HUMAN TISSUE;

EID: 84892902996     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000355432     Document Type: Article

References (10)

1. Kochhar R, Manoharan P, Leahy M, Taylor MB: Imaging in gastrointestinal stromal tumours: Current status and future directions. Clin Radiol 2010;65:584-592
2. Kalkmann J, Zeile M, Antoch G, Berger F, Diederich S, Dinter D, Fink C, Janka R, Stattaus J: Consensus report on the radiological management of patients with gastrointestinal stromal tumours (GIST): Recommendations of the German GIST Imaging Working Group. Cancer Imaging 2012;12:126-135
3. Miettinen M, Lasota J: Gastrointestinal stromal tumors: Pathology and prognosis at different sites. Semin Diagn Pathol 2006;23:70-83
4. Miettinen M, Majidi M, Lasota J: Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): A review. Eur J Cancer 2002;38(suppl 5):S39-S51
5. Kamiyama Y, Aihara R, Nakabayashi T, Mochiki E, Asao T, Kuwano H, Oriuchi N, Endo K: 18F-fluorodeoxyglucose positron emission tomography: Useful technique for predicting malignant potential of gastrointestinal stromal tumors. World J Surg 2005;29:1429-1435
6. Gayed I, Vu T, Iyer R, Johnson M, Macapinlac H, Swanston N, Podoloff D: The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors. J Nucl Med 2004;45:17-21
7. Park JW, Cho CH, Jeong DS, Chae HD: Role of F-fluoro-2-deoxyglucose positron emission tomography in gastric GIST: Predicting malignant potential pre-operatively. J Gastric Cancer 2011;11:173-179
8. Choi H, Charnsangavej C, de Castro Faria S, Tamm EP, Benjamin RS, Johnson MM, Macapinlac HA, Podoloff DA: CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: A quantitative analysis correlated with FDG PET findings. Am J Roentgenol 2004;183:1619-1628
9. Stroobants S, Goeminne J, Seegers M, Dimitrijevic S, Dupont P, Nuyts J, Martens M, van den Borne B, Cole P, Sciot R, Dumez H, Silberman S, Mortelmans L, van Oosterom A: 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). Eur J Cancer 2003;39:2012-2020
10. Demetri GD, von Mehren M, Antonescu CR, DeMatteo RP, Ganjoo KN, Maki RG, Pisters PW, Raut CP, Riedel RF, Schuetze S, Sundar HM, Trent JC, Wayne JD: NCCN Task Force report: Update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw 2010;8(suppl 2):S1-S41; quiz S42-S44